Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 76 of 2035 for:    Smoking Cessation

Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study) (Quit2Heal)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03600038
Recruitment Status : Active, not recruiting
First Posted : July 25, 2018
Last Update Posted : April 4, 2019
Sponsor:
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center

Brief Summary:
The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Condition or disease Intervention/treatment Phase
Cancer Smoking Behavioral: Experimental smoking cessation smartphone app Behavioral: Standard of care smoking cessation smartphone app Not Applicable

Detailed Description:
Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 66 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)
Actual Study Start Date : April 2, 2018
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Experimental
This is the experimental arm of the study. This includes receiving the novel/experimental smoking cessation smartphone app. Therapy description of experimental app withheld to protect the integrity of the study.
Behavioral: Experimental smoking cessation smartphone app
The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.

Active Comparator: Control
This is the control arm of the study. This includes receiving the standard of care smoking cessation smartphone app. Therapy description of standard of care app withheld to protect the integrity of the study.
Behavioral: Standard of care smoking cessation smartphone app
The control intervention uses a standard of care smartphone smoking cessation app.




Primary Outcome Measures :
  1. 30-day point prevalence abstinence [ Time Frame: 2 months post randomization ]
    No smoking in the past 30 days, as reported 2 months post treatment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 18 or older
  • diagnosed with cancer in the past 12 months
  • has smoked a cigarette (even a puff) in the past 30 days
  • interested in learning skills to quit smoking
  • willing to be randomly assigned to either smartphone application
  • resides in US
  • has at least daily access to their own smartphone
  • knows how to login and download a smartphone application from the Apple app store or Android Play app store
  • willing and able to read in English
  • not currently using cessation medications or enrolled in other smoking cessation programs, and
  • has never used the NCI's Quit Guide smartphone application.
  • willing and able to complete one follow-up survey
  • willing to provide email, phone, and mailing address.

Exclusion Criteria:

  • The exclusion criteria are opposite of the inclusion criteria listed above.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03600038


Locations
Layout table for location information
United States, Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109
Sponsors and Collaborators
Fred Hutchinson Cancer Research Center

Additional Information:
Layout table for additonal information
Responsible Party: Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier: NCT03600038     History of Changes
Other Study ID Numbers: 8630
First Posted: July 25, 2018    Key Record Dates
Last Update Posted: April 4, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Fred Hutchinson Cancer Research Center:
Smoking cessation
App for quitting smoking
Cancer
Oncology